1 drug(s) with this reaction
564 total reports
Injection Site Pain has been reported as an adverse reaction across 1 drug(s) manufactured by Ipsen Biopharmaceuticals Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 564 adverse event reports mention injection site pain in connection with Ipsen Biopharmaceuticals Inc products.
This page provides a breakdown of which Ipsen Biopharmaceuticals Inc drugs are most commonly associated with injection site pain, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Ipsen Biopharmaceuticals Inc drugs have injection site pain listed in their FDA adverse event reports, sorted by report count:
In addition to injection site pain, the following adverse reactions have been reported across Ipsen Biopharmaceuticals Inc's drug portfolio:
1 drug(s) manufactured by Ipsen Biopharmaceuticals Inc have injection site pain listed in their FDA adverse event reports: LANREOTIDE ACETATE.
There are a combined 564 reports of injection site pain across 1 Ipsen Biopharmaceuticals Inc drug(s) in the FDA adverse event database.